TY - JOUR AU - Weber, K. AU - Spirk, D. AU - Pieper, M. AU - Kucher, N. PY - 2009 DA - 2009// TI - Clinical efficacy and safety of enoxaparin in unselected Swiss patients undergoing primary or elective percutaneous coronary intervention: analysis of the RIVIERA study JO - Acta Cardiol VL - 64 UR - https://doi.org/10.2143/AC.64.4.2041609 DO - 10.2143/AC.64.4.2041609 ID - Weber2009 ER - TY - JOUR AU - Mehta, S. R. AU - Granger, C. B. AU - Eikelboom, J. W. AU - Bassand, J. P. AU - Wallentin, L. AU - Faxon, D. P. AU - Peters, R. J. AU - Budaj, A. AU - Afzal, R. AU - Chrolavicius, S. AU - Fox, K. A. AU - Yusuf, S. PY - 2007 DA - 2007// TI - Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial JO - J Am Coll Cardiol VL - 50 UR - https://doi.org/10.1016/j.jacc.2007.07.042 DO - 10.1016/j.jacc.2007.07.042 ID - Mehta2007 ER - TY - JOUR AU - Puymirat, E. AU - Schiele, F. AU - Ennezat, P. V. AU - Coste, P. AU - Collet, J. P. AU - Bonnefoy-Cudraz, E. AU - Roul, G. AU - Richard, P. AU - Simon, T. AU - Danchin, N. PY - 2015 DA - 2015// TI - Impact of fondaparinux versus enoxaparin on in-hospital bleeding and 1-year death in non-ST-segmentelevation myocardial infarction. FAST-MI (French Registry of acute ST-elevation and non-ST-elevation myocardial infarction) 2010 JO - Eur Heart J Acute Cardiovasc Care VL - 4 UR - https://doi.org/10.1177/2048872614544857 DO - 10.1177/2048872614544857 ID - Puymirat2015 ER - TY - STD TI - The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med. 1985. 4;312(14):932–6. ID - ref4 ER - TY - JOUR AU - Liberati, A. AU - Altman, D. G. AU - Tetzlaff, J. PY - 2009 DA - 2009// TI - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcareinterventions: explanation and elaboration JO - BMJ VL - 339 UR - https://doi.org/10.1136/bmj.b2700 DO - 10.1136/bmj.b2700 ID - Liberati2009 ER - TY - JOUR AU - Higgins, J. P. AU - Thompson, S. G. AU - Deeks, J. J. PY - 2003 DA - 2003// TI - Measuring inconsistency in meta-analyses JO - BMJ VL - 327 UR - https://doi.org/10.1136/bmj.327.7414.557 DO - 10.1136/bmj.327.7414.557 ID - Higgins2003 ER - TY - JOUR AU - Higgins, J. P. T. AU - Thompson, S. G. AU - Deeks, J. J. AU - Altman, D. G. PY - 2003 DA - 2003// TI - Measuring inconsistency in meta-analyses JO - BMJ VL - 327 UR - https://doi.org/10.1136/bmj.327.7414.557 DO - 10.1136/bmj.327.7414.557 ID - Higgins2003 ER - TY - JOUR AU - Bauer, K. A. PY - 2001 DA - 2001// TI - Fondaparinux sodium: a selective inhibitor of factor Xa JO - Am J Health Syst Pharm VL - 58 ID - Bauer2001 ER - TY - JOUR AU - Yau, J. W. AU - Stafford, A. R. AU - Liao, P. AU - Fredenburgh, J. C. AU - Roberts, R. AU - Weitz, J. I. PY - 2011 DA - 2011// TI - Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-07-364141 DO - 10.1182/blood-2011-07-364141 ID - Yau2011 ER - TY - JOUR AU - Soeiro, A. M. AU - Silva, P. G. AU - Roque, E. A. AU - Bossa, A. S. AU - César, M. C. AU - Simões, S. A. AU - Okada, M. Y. AU - Leal, T. C. AU - Pedroti, F. C. AU - Oliveira, M. T. PY - 2016 DA - 2016// TI - Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data JO - Arq Bras Cardiol VL - 107 ID - Soeiro2016 ER - TY - JOUR AU - Yusuf, S. AU - Mehta, S. R. AU - Chrolavicius, S. AU - Afzal, R. AU - Pogue, J. AU - Granger, C. B. AU - Budaj, A. AU - Peters, R. J. AU - Bassand, J. P. AU - Wallentin, L. AU - Joyner, C. AU - Fox, K. A. PY - 2006 DA - 2006// TI - Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial JO - JAMA VL - 295 UR - https://doi.org/10.1001/jama.295.13.joc60038 DO - 10.1001/jama.295.13.joc60038 ID - Yusuf2006 ER - TY - STD TI - Zhao XM, Gao CY, Chu YJ, Yang L, Yang XZ, Xu WK, He WQ, Zhang PR, Liu XY, Tian LX. Fondaparinux vs. enoxaparin in patients with non-ST elevation acute coronary syndromes (NSTE-ACS) treated with percutaneous coronary intervention and tirofiban: an exploratory study in China. J Clin Pharm Ther. 2015. ID - ref12 ER - TY - JOUR AU - Iannaccone, M. AU - Quadri, G. AU - Taha, S. PY - 2016 DA - 2016// TI - Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta-analysis JO - Eur Heart J Cardiovasc Imaging VL - 17 UR - https://doi.org/10.1093/ehjci/jev283 DO - 10.1093/ehjci/jev283 ID - Iannaccone2016 ER - TY - JOUR AU - Schiele, F. AU - Meneveau, N. AU - Seronde, M. F. AU - Descotes-Genon, V. AU - Dutheil, J. AU - Chopard, R. AU - Ecarnot, F. AU - Bassand, J. P. PY - 2010 DA - 2010// TI - Routine use of fondaparinux in acute coronary syndromes: a 2-year multicenter experience JO - Am Heart J VL - 159 UR - https://doi.org/10.1016/j.ahj.2009.11.003 DO - 10.1016/j.ahj.2009.11.003 ID - Schiele2010 ER - TY - JOUR AU - Shah, S. AU - Khajuria, V. AU - Tandon, V. R. AU - Gillani, Z. H. AU - Lal, M. PY - 2014 DA - 2014// TI - Comparative evaluation of efficacy, safety and haemostatic parameters of enoxaparin and fondaparinuxin unstable coronary artery disease JO - J Clin Diagn Res VL - 8 ID - Shah2014 ER - TY - JOUR AU - Zhao, X. AU - Yang, X. X. AU - Ji, S. Z. AU - Wang, X. Z. AU - Wang, L. AU - Gu, C. H. AU - Ren, L. L. AU - Han, Y. L. PY - 2016 DA - 2016// TI - Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronaryintervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban JO - Mil Med Res VL - 3 UR - https://doi.org/10.1186/s40779-016-0081-6 DO - 10.1186/s40779-016-0081-6 ID - Zhao2016 ER -